Neurology patient groups have chided the pharma industry for investing too little into treating disorders of the nervous ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...

Dementia-friendly travel options such as cruises and guided tours are needed to support a growing population of families and ...

New recommendations to help healthcare providers explain amyloid therapies to Alzheimer’s patients and their caregivers involve sharing the benefits and risks of the medications.

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence ... by early 2025 our Memory Center will be ...

A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather than a uniform progression. These findings may pave the way for ...

The University of South Florida announced a $6.5 million estate gift that will go toward the USF Health Byrd Alzheimer’s Center & Research Institute.

Researchers at Washington University School of Medicine in St. Louis have identified new drug targets for Alzheimer’s disease by studying cerebrospinal fluid (CSF) from living patients. This fluid, ...

For both patients and loved ones, she recommended the Alzheimer’s Association’s website. “They have a lot of resources for ...

Antibody makeup influences the severity of flu. Viruses are the fastest-evolving biological entity on earth. This fact ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...